Clinical Trials Browser

Phase 2 × Interventional × Advanced NSCLC Patients With T790M × Clear all

NCT03452592 2025-04-03

Efficacy and Safety of Alflutinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer Patients With T790M

Phase 2 Terminated

Advanced NSCLC Patients With T790M